Standout Papers
Citation Impact
Citing Papers
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 StandoutScience
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-Sodium)
1999
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease
2007
Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension
2003
Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study
2001
Genetic factors in end-stage renal disease
2005
Glucocorticoid-Remediable Aldosteronism
2003
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
2008
Targeted Disruption of the β2 Adrenergic Receptor Gene
1999 StandoutNobel
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort
1996
The influence of dietary and nondietary calcium supplementation on blood pressure An updated metaanalysis of randomized controlled trials
1999
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Global burden of hypertension: analysis of worldwide data
2005 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Glucocorticoid-remediable Aldosteronism
2011
Renal-Artery Stenosis
2001 Standout
Development and validation of brief measures of positive and negative affect: The PANAS scales.
1988 Standout
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning
2002
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
β-2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study
1998
Uric Acid and Cardiovascular Risk
2008 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Glucocorticoid-remediable Aldosteronism in a Large Kindred: Clinical Spectrum and Diagnosis Using a Characteristic Biochemical Phenotype
1992
Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology1
2000
Ischemic renal diseases: New insights into old entities
1998
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma
2007
Prediction of bone density from vitamin D receptor alleles
1994 StandoutNature
Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension
2002
Hypertension in developing nations in sub-Saharan Africa
2000
Racial differences in coronary calcium prevalence among high-risk adults
1995
Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension
1988
Renal Artery Stent Placement for the Management of Ischemic Nephropathy
1998
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
PATHOPHYSIOLOGY AND TREATMENT IMPLICATIONS OF HYPERTENSION IN THE AFRICAN-AMERICAN POPULATION
1997
Increased Blood Pressure during Potassium Depletion in Normotensive Men
1989
Race and Genomics
2003
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial
2004
A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable Aldosteronism
2008
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Natriuretic Peptides
1998 Standout
Male–female differences in fertility and blood pressure in ACE-deficient mice
1995 StandoutNatureNobel
Blood Pressure and End-Stage Renal Disease in Men
1996 Standout
Cardiac Dimensions Are Largely Determined by Dietary Salt in Patients with Primary Aldosteronism: Results of a Case-Control Study
2011
NHANES III
2007
Familial hyperaldosteronism
2001
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
The Application of Molecular Genetics to the Study of Familial Arterial Hypertension
1989
$alpha;2-Adrenergic Receptor Gene Polymorphism and Hypertension in Blacks
1995
Renal Insufficiency in Treated Essential Hypertension
1989
ACE inhibitors in renovascular hypertension
1990
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
2008 Standout
Severity of Hypertension in Familial Hyperaldosteronism Type I: Relationship to Gender and Degree of Biochemical Disturbance1
2000
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Concomitant Angiotensin AT1 Receptor Antagonism and Neprilysin Inhibition Produces Omapatrilat-like Antihypertensive Effects Without Promoting Tracheal Plasma Extravasation in the Rat
2011
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies
2012
The Effect of Race on Access and Outcome in Transplantation
1991
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase
1992
Renal Disease in Hypertensive Adults: Effect of Race and Type II Diabetes Mellitus
1989
Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension
1992
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling
2005
A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
1992 StandoutNature
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty
1993
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
Ethnic Disparities in Diabetic Complications in an Insured Population
2002 Standout
Diagnosis and Treatment of Primary Aldosteronism
2011
Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide
1995 Nature
Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial
1997
Molecular Genetics of Human Blood Pressure Variation
1996 Science
Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism
2007
Racial Differences in Sensitivity of Blood Pressure to Aldosterone
2014
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Involutional Osteoporosis
1986 Standout
Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients.
1989
Plasma catecholamines and essential hypertension. An analytical review.
1983
Preserving renal function in adults with hypertension and diabetes: A consensus approach
2000
Primary Aldosteronism
1979
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
The Spectrum of Vasculitis
1978 Standout
Self-efficacy mechanism in human agency.
1982 Standout
By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.
1991
Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension.
1988
Renal Revascularization in the Azotemic Hypertensive Patient Resistant to Therapy
1984
Evidence for alteration of the vitamin D-endocrine system in blacks.
1985
Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events
1981 Standout
Clinical outcome and health care costs in renal revascularization — percutaneous transluminal renal angioplasty versus reconstructive surgery
1991
Racial and ethnic modifiers of the salt-blood pressure response.
1991
Primary Aldosteronism
1988
A Global Measure of Perceived Stress
1983 Standout
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
1997
Association of Hypertension with β 2 - and α 2c10 -Adrenergic Receptor Genotype
1996
The Current Role of Renal Angioplasty in the Treatment of Renovascular Hypertension
1984
Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore1
2000
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma
2007
Further evaluation of saline infusion for the diagnosis of primary aldosteronism.
1984
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
2020 Standout
Renin-Angiotensin-Aldosterone and Hypertension
1980
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group.
1993
End-stage renal disease in African-American and white men. 16-year MRFIT findings.
1997
Etiologic factors in renovascular fibromuscular dysplasia. A case-control study.
1989
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Management of High Blood Pressure in Blacks
2010
Ischemic renal disease: An overlooked clinical entity?
1988
Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment
2009
Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition
2004
Renal Revascularization to Preserve and Restore Renal Function
1992
Unilateral renal artery revascularization can salvage renal function and terminate dialysis in selected patients with uremia
1993
Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure
2002
Revascularization to Preserve Renal Function in Patients with Atherosclerotic Renovascular Disease
1984
Relation between ingested potassium and sodium balance in young Blacks and whites
1983
Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
1981
Role of the α2B-Adrenergic Receptor in the Development of Salt-Induced Hypertension
1999 StandoutNobel
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
The stress and coping paradim
1981
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Effect of Calcium Channel or β-Blockade on the Progression of Diabetic Nephropathy in African Americans
1997
Genetic Study of Patients with Dexamethasone-Suppressible Aldosteronism without the Chimeric CYP11B1/CYP11B2 Gene
2001
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of Clarence E. Grim being referenced
The effect of a household partner and home urine monitoring on adherence to a sodium restricted diet
1991
Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: The African-American study of kidney disease and hypertension pilot study1
1997
Aldosterone and Alterations of Hypertension-Related Vascular Function in African Americans
2009
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension
2002
A familial risk of chronic renal failure among blacks on dialysis?
1988
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
2006
The effects of calcium supplementation on ambulatory blood pressure in African-American adolescents.
1996
Childhood primary aldosteronism with bilateral adrenocortical hyperplasia: Plasma renin activity as an aid to diagnosis
1967
Diagnosis of Secondary Forms of Hypertension
1977
Association of blood groups with essential and secondary hypertension. A possible association of the MNS system.
1979
Hyperaldosteronism and Hypertension
2005
Genetic Influences on Plasma and Urinary Norepinephrine after Volume Expansion and Contraction in Normal Men*
1980
Percutaneous Transluminal Dilatation in the Treatment of Renal Vascular Hypertension
1981
Nocturnal urinary electrolyte excretion and its relationship to the renin system and sympathetic activity in normal and hypertensive man.
1980
Omapatrilat Versus Lisinopril
2001
Diagnosis of secondary forms of hypertension. A comprehensive protocol
1977
Circadian variation of blood pressure in blacks: influence of age, gender and activity.
1990
Percutaneous Transluminal Angioplasty in Complicated Renal Vascular Hypertension
1986
Dynamic responses of active and inactive renin in normal and hypertensive humans.
1977
Unilateral Hypersecretion of Aldosterone Associated with Adrenal Hyperplasia as a Cause of Primary Aldosteronism
1983
Plasma and urinary norepinephrine values at extremes of sodium intake in normal man.
1979
Diagnosis and localization of pheochromocytoma
1979
Results of Surgical Treatment of Renovascular Hypertension
1979
Anomalous Postural Aldosterone Response in Glucocorticoid-Suppressible Hyperaldosteronism
1981
The Effect of Posture and Saline Loading on Plasma Renin Activity and Aldosterone Concentration in Pregnant,Non-Pregnant and Estrogen-Treated Women
1977
The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.
1987
Occlusion of the artery to a solitary kidney. Restoration of renal function after prolonged anuria.
1974
Fibromuscular dysplasia of the renal artery with medial dissection
1974
Treatment of Renal Artery Stenosis with Percutaneous Transluminal Angioplasty
1985
Sensitivity and Specificity of Screening Tests for Renal Vascular Hypertension
1979
Entering medical students, who say they have been trained to take blood pressure, do not follow the American heart association guidelines.
1999
Suppression of Renin and Aldosterone by Small Amounts of DOCA in Normal Man
1975
Surgery or Angioplasty for Cost-effective Renal Revascularization?
1987
Low Renin "Essential" Hypertension
1975
Association of haptoglobin with sodium sensitivity and resistance of blood pressure.
1987
ELEVATED URINARY EXCRETION OF 18-OXOCORTISOL IN GLUCOCORTICOID-SUPPRESSIBLE ALDOSTERONISM
1984
Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults
1987
Intervention in Patients with Renovascular Hypertension and Renal Insufficiency
1983
Norepinephrine in urine and plasma following provocative maneuvers in normal and hypertensive subjects.
1980
Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension
2001
Racial differences in blood pressure in evans county, Georgia: Relationship to sodium and potassium intake and plasma renin activity
1980
Blood pressure variation in blacks: genetic factors.
1996
Childhood Primary Aldosteronism Due to an Adrenal Adenoma: Preoperative Localization by Adrenal Vein Catheterization
1980
Sodium sensitivity and resistance in normotensive humans
1982
Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages.
1979
The effects of age, race and heredity on glomerular filtration rate following volume expansion and contraction in normal man
1980
The pathogenesis of hypertension: black-white differences.
1991
Hyperaldosteronism Due to Unsuspected Adrenal carcinoma: Discovery During Investigation of hypertension in a Young Woman
1981
Familial, Dexamethasone-Suppressible, Normokalemic Hyperaldosteronism
1980
A model for the social sciences and medicine: The case for hypertension
1975
Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses.
1991
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men.
1979
Genetic and Pathophysiologic Studies of a New Kindred with Glucocorticoid-Suppressible Hyperaldosteronism Manifest in Three Generations*
1981
A curriculum for the training and certification of blood pressure measurement for health care providers.
1995
GENETIC, FAMILIAL AND RACIAL INFLUENCES ON BLOOD PRESSURE CONTROL SYSTEMS IN MAN
1984
Diagnosis of secondary forms of hypertension. A comprehensive protocol.
1977
Biohistory of slavery and blood pressure differences in blacks today. A hypothesis.
1991
Definitions and characteristics of sodium sensitivity and blood pressure resistance.
1986 Standout